GLP-1 Microdose Programs 2026: Provider Costs Compared ($82–$249/mo)

What microdosing programs actually are

"GLP-1 microdose" programs prescribe sub-therapeutic doses — typically 0.2–1 mg/week of semaglutide (vs the 2.4 mg studied maintenance dose) — for appetite control, weight maintenance after reaching goal, or patients with BMI 20–25 who don't qualify for standard treatment. For the evidence and safety picture, read our GLP-1 microdosing explainer. This page compares who sells it and what it costs — because the "program" is really a compounded prescription plus a marketing label.

One honest caveat up front: a 2024 Diabetes Care analysis describes GLP-1 microdosing as off-label with no clinical trials validating safety or efficacy for weight outcomes. The tolerability logic is plausible; the weight-loss claims are marketing.

Providers offering microdose GLP-1 — verified September 2026

NexLife's tier is the most complete: microdose pricing announced August 31, 2026 sits below its standard program, billed monthly with cancel-anytime terms, and includes the Care360 coaching bundle — details in our NexLife review.

Is microdosing actually cheaper?

Barely. Compare the same providers' standard vs microdose rates: NexLife charges $139–$169 for standard tirzepatide vs $129–$159 microdose — a $10–20/mo difference. The reason is structural: the medication is a minority of program cost; evaluation, shipping, and support dominate. If a provider quotes microdose at near-full price, that's normal — not a rip-off. What you're buying is the prescribing pathway (lower BMI eligibility) and slower titration, not a cheaper molecule.

The theoretical saving is longevity: if microdosing helps maintain weight loss after reaching goal, you avoid paying maintenance-dose prices indefinitely. That's plausible — and unproven.

Who microdose programs are marketed to

• Post-goal maintenance: hit target weight, step down to 0.25–0.5mg instead of stopping cold — see our GLP-1 tapering guide
• BMI 20–25: patients ineligible for standard obesity treatment but wanting appetite/"food noise" control (WeightCare explicitly serves BMI 20+)
• Side-effect refugees: couldn't tolerate standard titration — fractional doses may improve GI tolerability
• Budget-limited: stretching supply — though as shown, the program cost barely drops

How microdose prescriptions actually work

All microdose programs use compounded semaglutide or tirzepatide — brand pens can't reliably deliver fractional doses (the one exception: semaglutide multidose pens allow ~72 "click" fractional doses, a technique described in the clinical literature for diabetes patients). Compounded microdose requires a prescriber's medical-necessity determination — every legitimate provider runs an intake + clinician review. Any program selling "microdose" without a provider consultation is a red flag.

Bottom line

Microdose GLP-1 is a real, growing program category — but it's a prescribing philosophy, not a discount product. NexLife offers the best-structured microdose option (both molecules, monthly billing, coaching included, from $109/mo); Telezen is cheapest at $82/mo on multi-month prepay. Go in knowing the evidence base is thin — you're paying a modest premium-or-parity price for an off-label, unvalidated use case. Compare the full market in our GLP-1 Price Index.

Affiliate disclosure: This article contains affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. GLP-1 microdosing is an off-label practice not validated in clinical trials; compounded medications are not FDA-approved as finished products. Pricing verified September 2026 — confirm at checkout.